Going forward...19 Nov 2021 09:50
Sometimes you have to read between the lines on things and given the ABDX RNS this week, I have read between the lines and seen that for this first time this week, tangible evidence that 78m and possibly more in the way of extended deals to battle the rise across Europe in Covid will be settled into NCYT's account sooner rather than later.It's worth stopping and thinking what that means. The Cash at the bank will be equal near as damn it to the MCAP at 180m.Now if you have 180m in the bank and are still selling world wide for another 2 years into covid and develop and non covid revenue of 25-30m a year through our newly established world wide distribution and sales network, I do think we will be looking at much high prices.I'm looking for £8 on a successful resolution of the DHSC dispute and £10 plus once the forward strategy in known and £12-15 as this strategy develops and starts to bring in the aforementioned revenues.It's not rocket science where this is going and people will, IMO, kick then selves for not buying at under £4 when one stroke of the ink sign off on the DHSC, takes us to £8 before we strategy getting valued on x10/x15 PE of our long term Covid/Non Covid revenues.DYOR, no advice intended and just my thoughts.